tiprankstipranks
Surgical Science Sweden AB (SUSRF)
OTHER OTC:SUSRF
US Market
SUSRF
Surgical Science Sweden AB
RESEARCH TOOLSreports

Surgical Science Sweden AB (SUSRF) Ratios

3 Followers

Surgical Science Sweden AB Ratios

SUSRF's free cash flow for Q2 2026 was kr0.61. For the 2026 fiscal year, SUSRF's free cash flow was decreased by kr and operating cash flow was kr0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.24 4.07 2.78 4.22 2.70
Quick Ratio
 3.45 3.36 2.43 3.56 2.26
Cash Ratio
 2.22 2.12 1.89 2.70 1.42
Solvency Ratio
 0.43 0.36 0.30 0.81 0.56
Operating Cash Flow Ratio
 0.50 0.27 0.27 1.01 0.42
Short-Term Operating Cash Flow Coverage
 0.00 3.55 7.36 0.00 0.00
Net Current Asset Value
kr 840.07Mkr 766.37Mkr 774.97Mkr 633.73Mkr 413.26M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.02 0.05 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 0.02 0.06 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 0.02 0.06 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 <0.01 0.00 0.05 0.00 0.00
Financial Leverage Ratio
 1.09 1.10 1.13 1.08 1.10
Debt Service Coverage Ratio
 43.69 5.53 8.13 442.44 192.41
Interest Coverage Ratio
 29.01 17.34 25.41 288.34 124.55
Debt to Market Cap
 <0.01 0.01 0.03 0.00 0.00
Interest Debt Per Share
 0.15 1.67 5.84 0.80 0.31
Net Debt to EBITDA
 -2.68 -2.79 -3.01 -1.83 -1.54
Profitability Margins
Gross Profit Margin
62.24%58.14%67.63%69.42%66.23%
EBIT Margin
14.14%10.98%18.52%30.46%28.37%
EBITDA Margin
23.95%19.38%25.37%36.76%33.80%
Operating Profit Margin
13.77%10.98%16.32%21.43%20.25%
Pretax Profit Margin
12.33%10.09%17.88%30.39%25.94%
Net Profit Margin
9.11%6.73%14.89%26.50%23.42%
Continuous Operations Profit Margin
9.11%6.73%14.89%26.50%23.42%
Net Income Per EBT
73.89%66.73%83.27%87.22%90.30%
EBT Per EBIT
89.52%91.89%109.54%141.82%128.08%
Return on Assets (ROA)
1.87%1.42%2.40%4.98%4.04%
Return on Equity (ROE)
2.12%1.56%2.73%5.38%4.44%
Return on Capital Employed (ROCE)
3.01%2.48%2.91%4.23%3.74%
Return on Invested Capital (ROIC)
2.23%1.64%2.41%3.69%3.38%
Return on Tangible Assets
6.62%5.17%8.48%21.52%20.79%
Earnings Yield
3.64%4.03%1.65%2.52%2.25%
Efficiency Ratios
Receivables Turnover
 4.87 3.43 3.42 7.98 3.29
Payables Turnover
 0.00 11.46 4.90 6.54 4.13
Inventory Turnover
 1.65 2.02 1.59 1.75 2.01
Fixed Asset Turnover
 8.62 9.33 8.71 11.52 15.63
Asset Turnover
 0.21 0.21 0.16 0.19 0.17
Working Capital Turnover Ratio
 1.09 1.10 1.06 1.38 1.77
Cash Conversion Cycle
 296.23 255.50 261.07 198.72 204.21
Days of Sales Outstanding
 74.87 106.38 106.58 45.73 111.03
Days of Inventory Outstanding
 221.36 180.97 229.04 208.81 181.65
Days of Payables Outstanding
 0.00 31.85 74.54 55.82 88.47
Operating Cycle
 296.23 287.35 335.61 254.54 292.68
Cash Flow Ratios
Operating Cash Flow Per Share
 2.92 1.56 2.69 4.68 2.55
Free Cash Flow Per Share
 2.08 1.33 1.76 3.81 1.87
CapEx Per Share
 0.84 0.23 0.93 0.87 0.68
Free Cash Flow to Operating Cash Flow
 0.71 0.85 0.65 0.81 0.73
Dividend Paid and CapEx Coverage Ratio
 3.46 6.83 2.89 5.40 3.75
Capital Expenditure Coverage Ratio
 3.46 6.83 2.89 5.40 3.75
Operating Cash Flow Coverage Ratio
 52.20 1.01 0.47 5.95 8.82
Operating Cash Flow to Sales Ratio
 0.15 0.08 0.16 0.27 0.16
Free Cash Flow Yield
4.14%4.11%1.13%2.09%1.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 27.43 24.81 60.43 39.73 44.51
Price-to-Sales (P/S) Ratio
 2.51 1.67 9.00 10.53 10.43
Price-to-Book (P/B) Ratio
 0.56 0.39 1.65 2.14 1.97
Price-to-Free Cash Flow (P/FCF) Ratio
 24.15 24.35 88.69 47.87 88.13
Price-to-Operating Cash Flow Ratio
 17.18 20.78 57.97 39.01 64.62
Price-to-Earnings Growth (PEG) Ratio
 24.83 -0.50 -1.38 1.65 0.54
Price-to-Fair Value
 0.56 0.39 1.65 2.14 1.97
Enterprise Value Multiple
 7.78 5.83 32.45 26.81 29.30
Enterprise Value
 1.91B 1.12B 7.28B 8.70B 7.95B
EV to EBITDA
 7.78 5.83 32.45 26.81 29.30
EV to Sales
 1.86 1.13 8.23 9.85 9.90
EV to Free Cash Flow
 17.97 16.45 81.15 44.81 83.72
EV to Operating Cash Flow
 12.78 14.05 53.05 36.51 61.38
Tangible Book Value Per Share
 19.36 17.11 17.66 14.33 9.67
Shareholders’ Equity Per Share
 89.19 83.74 94.63 85.32 83.39
Tax and Other Ratios
Effective Tax Rate
 0.26 0.33 0.17 0.13 0.10
Revenue Per Share
 20.04 19.45 17.33 17.33 15.80
Net Income Per Share
 1.83 1.31 2.58 4.59 3.70
Tax Burden
 0.74 0.67 0.83 0.87 0.90
Interest Burden
 0.87 0.92 0.97 1.00 0.91
Research & Development to Revenue
 0.16 0.19 0.22 0.21 0.22
SG&A to Revenue
 0.27 0.28 0.29 0.08 0.08
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.49 1.19 1.04 1.02 0.80
Currency in SEK